Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |